- Home
- FBRX vs AHG Comparison
FBRX vs AHG Comparison
Compare FBRX & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBRX | AHG |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 899.4M | 1.1B |
| IPO Year | 2017 | 2017 |
Fundamental Metrics
Financial Performance| Metric | FBRX | AHG |
|---|---|---|
| Price | $76.89 | $1.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $67.00 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 8.0K |
| Earning Date | 05-14-2026 | 08-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.18 | $0.96 |
| 52 Week High | $77.20 | $2.50 |
Technical Indicators
Market Signals| Indicator | FBRX | AHG |
|---|---|---|
| Relative Strength Index (RSI) | 84.38 | 31.50 |
| Support Level | $26.85 | N/A |
| Resistance Level | $77.20 | $1.61 |
| Average True Range (ATR) | 0.11 | 0.13 |
| MACD | -1.75 | -0.05 |
| Stochastic Oscillator | 88.64 | 10.71 |
Price Performance
Historical ComparisonAbout FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
About AHG Akso Health Group ADS
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.